Chloride potassium symporter 5

Last updated
SLC12A5
Identifiers
Aliases SLC12A5 , KCC2, Chloride potassium symporter 5, EIEE34, EIG14, hKCC2, solute carrier family 12 member 5, DEE34
External IDs OMIM: 606726 MGI: 1862037 HomoloGene: 10665 GeneCards: SLC12A5
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_020708
NM_001134771

NM_020333
NM_001355480
NM_001355481

RefSeq (protein)

NP_001128243
NP_065759

NP_065066
NP_001342409
NP_001342410

Location (UCSC) Chr 20: 46.02 – 46.06 Mb Chr 2: 164.8 – 164.84 Mb
PubMed search [3] [4]
Wikidata
View/Edit Human View/Edit Mouse

Potassium-chloride transporter member 5 (aka: KCC2 and SLC12A5) is a neuron-specific chloride potassium symporter responsible for establishing the chloride ion gradient in neurons through the maintenance of low intracellular chloride concentrations. [5] It is a critical mediator of synaptic inhibition, cellular protection against excitotoxicity [6] [7] and may also act as a modulator of neuroplasticity. [8] [9] [10] [11] Potassium-chloride transporter member 5 is also known by the names: KCC2 (potassium chloride cotransporter 2) for its ionic substrates, and SLC12A5 for its genetic origin from the SLC12A5 gene in humans. [5]

Contents

Animals with reduced expression of this transporter exhibit severe motor deficits, epileptiform activity, and spasticity. [8] KCC2 knockout animals, in which KCC2 is completely absent, die postnatally due to respiratory failure. [8]

Location

KCC2 is a neuron-specific membrane protein expressed throughout the central nervous system, including the hippocampus, hypothalamus, brainstem, and motoneurons of the ventral spinal cord. [10]

At the subcellular level, KCC2 has been found in membranes of the somata and dendrites of neurons, [8] [12] with no evidence of expression on axons. [8] KCC2 has also been shown to colocalize with GABAA receptors, which serve as ligand-gated ion channels to allow chloride ion movement across the cell membrane. Under normal conditions, the opening of GABAA receptors permits the hyperpolarizing influx of chloride ions to inhibit postsynaptic neurons from firing. [7]

Counterintuitively, KCC2 has also been shown to colocalize at excitatory synapses. [6] One suggested explanation for such colocalization is a potential protective role of KCC2 against excitotoxicity. [6] [7] Ion influx due to the excitatory synaptic stimulation of ion channels in the neuronal membrane causes osmotic swelling of cells as water is drawn in alongside the ions. KCC2 may help to eliminate excess ions from the cell in order to re-establish osmotic homeostasis.

Structure

KCC2 is a member of the cation-chloride cotransporter (CCC) superfamily of proteins. [13]

As with all CCC proteins, KCC2 is an integral membrane protein with 12 transmembrane domains and both N- and C-terminal cytoplasmic domains. The terminal cytoplasmic domains can be phosphorylated by kinases within the neuron for rapid regulation.

Two Isoforms: KCC2a, KCC2b

There are two isoforms of KCC2: KCC2a and KCC2b. [8] [14] The two isoforms arise from alternative promoters on the SLC12A5 gene and differential splicing of the first mRNA exon. [8] [14] The isoforms differ in their N-termini, with the KCC2a form constituting the larger of the two splice variants. [15]

KCC2a levels remain relatively constant during pre- and postnatal development. [15]

KCC2b, on the other hand, is scarcely present during prenatal development and is strongly upregulated during postnatal development. The upregulation of KCC2b expression is thought to be responsible for the “developmental shift” observed in mammals from depolarizing postsynaptic effects of inhibitory synapses in early neural networks to hyperpolarizing effects in mature neural networks. [8]

KCC2b knockout mice can survive up to postnatal day 17 (P17) due to the presence of functional KCC2a alone, but they exhibit low body weight, motor deficits and generalized seizures. [8] Complete KCC2 knockouts (both KCC2a and KCC2b absent) die after birth due to respiratory failure. [8]

Oligomerization

Both KCC2 isoforms can form homomultimers, or heteromultimers with other K-Cl symporters on the cell membrane to maintain chloride homeostasis in neurons. [5] Dimers, trimers, and tetramers involving KCC2 have been identified in brainstem neurons. [16] Oligomerization may play an important role in transporter function and activation, as it has been observed that the oligomer to monomer ratio increases in correlation to the development of the chloride ion gradient in neurons. [16]

Developmental changes in expression

KCC2 levels are low during mammalian embryonic development, when neural networks are still being established and neurons are highly plastic (changeable). During this stage, intracellular chloride ion concentrations are high due to low KCC2 expression and high levels of a transporter known as NKCC1 (Na+/K+ chloride cotransporter 1), which moves chloride ions into cells. [17] Thus, during embryonic development, the chloride gradient is such that stimulation of GABAA receptors and glycine receptors at inhibitory synapses causes chloride ions to flow out of cells, making the internal neuronal environment less negative (i.e. more depolarized) than it would be at rest. At this stage, GABAA receptors and glycine receptors act as excitatory rather than inhibitory effectors on postsynaptic neurons, resulting in depolarization and hyperexcitability of neural networks. [8] [10] [11]

During postnatal development, KCC2 levels are strongly upregulated while NKCC1 levels are down regulated. [17] This change in expression correlates to a developmental shift of the chloride ion concentration within neurons from high to low intracellular concentration. Effectively, as the chloride ion concentration is reduced, the chloride gradient across the cellular membrane is reversed such that GABAA receptor and glycine receptor stimulation causes chloride ion influx, making the internal neuronal environment more negative (i.e. more hyperpolarized) than it would be at rest. This is the developmental shift of inhibitory synapses from the excitatory postsynaptic responses of the early neural development phase to the inhibitory postsynaptic responses observed throughout maturity.

Function

Current literature suggests that KCC2 serves three primary roles within neurons:

  1. Establishing the chloride ion gradient necessary for postsynaptic inhibition
  2. Protecting neuronal networks against stimulation-induced excitotoxicity
  3. Contributing to dendritic spine morphogenesis and glutamatergic synaptic function

Postsynaptic inhibition

KCC2 is a potassium (K+)/chloride (Cl) symporter that maintains chloride homeostasis in neurons. The electrochemical chloride gradient established by KCC2 activity is crucial for classical postsynaptic inhibition through GABAA receptors and glycine receptors in the central nervous system. KCC2 utilizes the potassium gradient generated by the Na+/K+ pump to drive chloride extrusion from neurons. [8] In fact, any disruption of the neuronal K+ gradient would indirectly affect KCC2 activity.

Loss of KCC2 following neuronal damage (i.e. ischemia, spinal cord damage, physical trauma to the central nervous system) results in the loss of inhibitory regulation and the subsequent development of neuronal hyperexcitability, motor spasticity, and seizure-like activity [10] as GABAA receptors and glycine receptors revert from hyperpolarizing to depolarizing postsynaptic effects.

Cellular protection

High levels of stimulation and subsequent ionic influx through activated ion channels can result in cellular swelling as osmotically-obliged water is drawn into neurons along with ionic solutes. This phenomenon is known as excitotoxicity. [6] KCC2 has been shown to be activated by cell-swelling, and may therefore play a role in eliminating excess ions following periods of high stimulation in order to maintain steady-state neuronal volume and prevent cells from bursting. [6]

This role may also account for the fact that KCC2 has been known to colocalize near excitatory synapses, even though its primary role is to establish the chloride gradient for postsynaptic inhibition. [6] [7]

Morphogenesis and function of glutamatergic synapses

In addition to controlling the efficacy of GABAergic synapses through chloride homeostasis, KCC2 play a critical role in the morphogenesis and function of glutamatergic synapses within the central nervous system. Studies on hippocampal tissue in KCC2 knockout animals showed that neurons lacking KCC2 have stunted dendritic growth and malformed dendritic spines. [8] Recent studies demonstrate that KCC2 plays a critical role in the structure and function of dendritic spines [9] which host most excitatory synapses in cortical neurons. Through an interaction with actin cytoskeleton, KCC2 forms a molecular barrier to the diffusion of transmembrane proteins within dendritic spines, thereby regulating the local confinement of AMPA receptors and synaptic potency. [9]

It has been proposed that the downregulation of KCC2 observed following neuronal trauma, and the consequent depolarizing shift of GABAA-mediated synapses, may be an aspect of neuronal de-differentiation. De-differentiation of damaged portions of the nervous system would allow for neuronal networks to return to higher levels of plasticity in order to rewire surviving neurons to compensate for damage in the network. [8] [10] [11] In addition, reduced glutamatergic transmission upon KCC2 downregulation may serve as a homeostatic process to compensate for the reduced GABA transmission due to altered chloride extrusion. [9]

Oncogenesis

Mutations in SLC12A5 are associated with colon cancer. [18]

Regulation

Transcriptional regulation: TrkB receptor signalling

KCC2 is transcriptionally downregulated following central nervous system injury by the TrkB receptor signalling transduction cascade (activated by BDNF and NT-4/5). [19] [20] [21]

Post-translational regulation: phosphorylation

It is conventionally thought that phosphorylation inactivates or downregulates KCC2, however there is recent evidence to suggest that phosphorylation at different sites on the KCC2 protein determines different regulational outcomes:

KCC2 has an extremely high rate of turnover at the plasmalemma (minutes), [8] suggesting that phosphorylation serves as the primary mechanism for rapid regulation.

Activity-dependent downregulation

KCC2 is downregulated by excitatory glutamate activity on NMDA receptor activity and Ca2+ influx. [11] [22] This process involves rapid dephosphorylation on Ser940 and calpain protease cleavage of KCC2, leading to enhanced membrane diffusion and endocytosis of the transporter, [23] as demonstrated in experiments using single particle tracking.

Glutamate release occurs not only at excitatory synapses, but is also known to occur after neuronal damage or ischemic insult. [11] Thus, activity-dependent downregulation may be the underlying mechanism by which KCC2 downregulation occurs following central nervous system injury.

See also

Related Research Articles

<span class="mw-page-title-main">Chemical synapse</span> Biological junctions through which neurons signals can be sent

Chemical synapses are biological junctions through which neurons' signals can be sent to each other and to non-neuronal cells such as those in muscles or glands. Chemical synapses allow neurons to form circuits within the central nervous system. They are crucial to the biological computations that underlie perception and thought. They allow the nervous system to connect to and control other systems of the body.

γ-Aminobutyric acid Main inhibitory neurotransmitter in the mammalian brain

γ-Aminobutyric acid, or GABA, is the chief inhibitory neurotransmitter in the developmentally mature mammalian central nervous system. Its principal role is reducing neuronal excitability throughout the nervous system.

<span class="mw-page-title-main">Reuptake</span> Reabsorption of a neurotransmitter by a neurotransmitter transporter

Reuptake is the reabsorption of a neurotransmitter by a neurotransmitter transporter located along the plasma membrane of an axon terminal or glial cell after it has performed its function of transmitting a neural impulse.

<span class="mw-page-title-main">Neurotransmitter receptor</span> Type of protein

A neurotransmitter receptor is a membrane receptor protein that is activated by a neurotransmitter. Chemicals on the outside of the cell, such as a neurotransmitter, can bump into the cell's membrane, in which there are receptors. If a neurotransmitter bumps into its corresponding receptor, they will bind and can trigger other events to occur inside the cell. Therefore, a membrane receptor is part of the molecular machinery that allows cells to communicate with one another. A neurotransmitter receptor is a class of receptors that specifically binds with neurotransmitters as opposed to other molecules.

An inhibitory postsynaptic potential (IPSP) is a kind of synaptic potential that makes a postsynaptic neuron less likely to generate an action potential. IPSPs were first investigated in motorneurons by David P. C. Lloyd, John Eccles and Rodolfo Llinás in the 1950s and 1960s. The opposite of an inhibitory postsynaptic potential is an excitatory postsynaptic potential (EPSP), which is a synaptic potential that makes a postsynaptic neuron more likely to generate an action potential. IPSPs can take place at all chemical synapses, which use the secretion of neurotransmitters to create cell to cell signalling. Inhibitory presynaptic neurons release neurotransmitters that then bind to the postsynaptic receptors; this induces a change in the permeability of the postsynaptic neuronal membrane to particular ions. An electric current that changes the postsynaptic membrane potential to create a more negative postsynaptic potential is generated, i.e. the postsynaptic membrane potential becomes more negative than the resting membrane potential, and this is called hyperpolarisation. To generate an action potential, the postsynaptic membrane must depolarize—the membrane potential must reach a voltage threshold more positive than the resting membrane potential. Therefore, hyperpolarisation of the postsynaptic membrane makes it less likely for depolarisation to sufficiently occur to generate an action potential in the postsynaptic neurone.

In neurophysiology, long-term depression (LTD) is an activity-dependent reduction in the efficacy of neuronal synapses lasting hours or longer following a long patterned stimulus. LTD occurs in many areas of the CNS with varying mechanisms depending upon brain region and developmental progress.

<span class="mw-page-title-main">Membrane potential</span> Type of physical quantity

Membrane potential is the difference in electric potential between the interior and the exterior of a biological cell. That is, there is a difference in the energy required for electric charges to move from the internal to exterior cellular environments and vice versa, as long as there is no acquisition of kinetic energy or the production of radiation. The concentration gradients of the charges directly determine this energy requirement. For the exterior of the cell, typical values of membrane potential, normally given in units of milli volts and denoted as mV, range from –80 mV to –40 mV.

<span class="mw-page-title-main">Excitatory synapse</span> Sort of synapse

An excitatory synapse is a synapse in which an action potential in a presynaptic neuron increases the probability of an action potential occurring in a postsynaptic cell. Neurons form networks through which nerve impulses travels, each neuron often making numerous connections with other cells of neurons. These electrical signals may be excitatory or inhibitory, and, if the total of excitatory influences exceeds that of the inhibitory influences, the neuron will generate a new action potential at its axon hillock, thus transmitting the information to yet another cell.

<span class="mw-page-title-main">Cotransporter</span> Type of membrane transport proteins

Cotransporters are a subcategory of membrane transport proteins (transporters) that couple the favorable movement of one molecule with its concentration gradient and unfavorable movement of another molecule against its concentration gradient. They enable coupled or cotransport and include antiporters and symporters. In general, cotransporters consist of two out of the three classes of integral membrane proteins known as transporters that move molecules and ions across biomembranes. Uniporters are also transporters but move only one type of molecule down its concentration gradient and are not classified as cotransporters.

GABA<sub>A</sub> receptor Ionotropic receptor and ligand-gated ion channel

The GABAA receptor (GABAAR) is an ionotropic receptor and ligand-gated ion channel. Its endogenous ligand is γ-aminobutyric acid (GABA), the major inhibitory neurotransmitter in the central nervous system. Accurate regulation of GABAergic transmission through appropriate developmental processes, specificity to neural cell types, and responsiveness to activity is crucial for the proper functioning of nearly all aspects of the central nervous system (CNS). Upon opening, the GABAA receptor on the postsynaptic cell is selectively permeable to chloride ions (Cl) and, to a lesser extent, bicarbonate ions (HCO3).

Neuropharmacology is the study of how drugs affect function in the nervous system, and the neural mechanisms through which they influence behavior. There are two main branches of neuropharmacology: behavioral and molecular. Behavioral neuropharmacology focuses on the study of how drugs affect human behavior (neuropsychopharmacology), including the study of how drug dependence and addiction affect the human brain. Molecular neuropharmacology involves the study of neurons and their neurochemical interactions, with the overall goal of developing drugs that have beneficial effects on neurological function. Both of these fields are closely connected, since both are concerned with the interactions of neurotransmitters, neuropeptides, neurohormones, neuromodulators, enzymes, second messengers, co-transporters, ion channels, and receptor proteins in the central and peripheral nervous systems. Studying these interactions, researchers are developing drugs to treat many different neurological disorders, including pain, neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease, psychological disorders, addiction, and many others.

<span class="mw-page-title-main">Glycine receptor</span> Widely distributed inhibitory receptor in the central nervous system

The glycine receptor is the receptor of the amino acid neurotransmitter glycine. GlyR is an ionotropic receptor that produces its effects through chloride current. It is one of the most widely distributed inhibitory receptors in the central nervous system and has important roles in a variety of physiological processes, especially in mediating inhibitory neurotransmission in the spinal cord and brainstem.

Molecular neuroscience is a branch of neuroscience that observes concepts in molecular biology applied to the nervous systems of animals. The scope of this subject covers topics such as molecular neuroanatomy, mechanisms of molecular signaling in the nervous system, the effects of genetics and epigenetics on neuronal development, and the molecular basis for neuroplasticity and neurodegenerative diseases. As with molecular biology, molecular neuroscience is a relatively new field that is considerably dynamic.

An autoreceptor is a type of receptor located in the membranes of nerve cells. It serves as part of a negative feedback loop in signal transduction. It is only sensitive to the neurotransmitters or hormones released by the neuron on which the autoreceptor sits. Similarly, a heteroreceptor is sensitive to neurotransmitters and hormones that are not released by the cell on which it sits. A given receptor can act as either an autoreceptor or a heteroreceptor, depending upon the type of transmitter released by the cell on which it is embedded.

Glutamate transporters are a family of neurotransmitter transporter proteins that move glutamate – the principal excitatory neurotransmitter – across a membrane. The family of glutamate transporters is composed of two primary subclasses: the excitatory amino acid transporter (EAAT) family and vesicular glutamate transporter (VGLUT) family. In the brain, EAATs remove glutamate from the synaptic cleft and extrasynaptic sites via glutamate reuptake into glial cells and neurons, while VGLUTs move glutamate from the cell cytoplasm into synaptic vesicles. Glutamate transporters also transport aspartate and are present in virtually all peripheral tissues, including the heart, liver, testes, and bone. They exhibit stereoselectivity for L-glutamate but transport both L-aspartate and D-aspartate.

The Na–K–Cl cotransporter (NKCC) is a transport protein that aids in the secondary active transport of sodium, potassium, and chloride into cells. In humans there are two isoforms of this membrane transport protein, NKCC1 and NKCC2, encoded by two different genes. Two isoforms of the NKCC1/Slc12a2 gene result from keeping or skipping exon 21 in the final gene product.

In molecular biology, the electroneutral cation-Cl family of proteins are a family of solute carrier proteins. This family includes the products of the Human genes: SLC12A1, SLC12A1, SLC12A2, SLC12A3, SLC12A4, SLC12A5, SLC12A6, SLC12A7, SLC12A8 and SLC12A9.

<span class="mw-page-title-main">Calyx of Held</span>

The Calyx of Held is a particularly large synapse in the mammalian auditory central nervous system, so named after Hans Held who first described it in his 1893 article Die centrale Gehörleitung because of its resemblance to the calyx of a flower. Globular bushy cells in the anteroventral cochlear nucleus (AVCN) send axons to the contralateral medial nucleus of the trapezoid body (MNTB), where they synapse via these calyces on MNTB principal cells. These principal cells then project to the ipsilateral lateral superior olive (LSO), where they inhibit postsynaptic neurons and provide a basis for interaural level detection (ILD), required for high frequency sound localization. This synapse has been described as the largest in the brain.

<span class="mw-page-title-main">DLG4</span> Mammalian protein found in Homo sapiens

PSD-95 also known as SAP-90 is a protein that in humans is encoded by the DLG4 gene.

<span class="mw-page-title-main">WNK1</span> Protein-coding gene in the species Homo sapiens

WNK , also known as WNK1, is an enzyme that is encoded by the WNK1 gene. WNK1 is serine-threonine protein kinase and part of the "with no lysine/K" kinase WNK family. The predominant role of WNK1 is the regulation of cation-Cl cotransporters (CCCs) such as the sodium chloride cotransporter (NCC), basolateral Na-K-Cl symporter (NKCC1), and potassium chloride cotransporter (KCC1) located within the kidney. CCCs mediate ion homeostasis and modulate blood pressure by transporting ions in and out of the cell. WNK1 mutations as a result have been implicated in blood pressure disorders/diseases; a prime example being familial hyperkalemic hypertension (FHHt).

References

  1. 1 2 3 GRCh38: Ensembl release 89: ENSG00000124140 - Ensembl, May 2017
  2. 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000017740 - Ensembl, May 2017
  3. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. 1 2 3 "Entrez Gene: SLC12A5 solute carrier family 12, (potassium-chloride transporter) member 5".
  6. 1 2 3 4 5 6 Watanabe M, Wake H, Moorhouse AJ, Nabekura J (October 2009). "Clustering of neuronal K+-Cl cotransporters in lipid rafts by tyrosine phosphorylation". J. Biol. Chem. 284 (41): 27980–8. doi: 10.1074/jbc.M109.043620 . PMC   2788850 . PMID   19679663.
  7. 1 2 3 4 Gulyás AI, Sík A, Payne JA, Kaila K, Freund TF (June 2001). "The KCl cotransporter, KCC2, is highly expressed in the vicinity of excitatory synapses in the rat hippocampus". Eur. J. Neurosci. 13 (12): 2205–17. doi: 10.1046/j.0953-816x.2001.01600.x . PMID   11454023. S2CID   22312687.
  8. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Blaesse P, Airaksinen MS, Rivera C, Kaila K (March 2009). "Cation-chloride cotransporters and neuronal function". Neuron. 61 (6): 820–38. doi: 10.1016/j.neuron.2009.03.003 . PMID   19323993. S2CID   10181096.
  9. 1 2 3 4 Gauvain G, Chamma I, Chevy Q, Cabezas C, Irinopoulou T, Bodrug N, Carnaud M, Lévi S, Poncer JC (September 2011). "The neuronal K-Cl cotransporter KCC2 influences postsynaptic AMPA receptor content and lateral diffusion in dendritic spines". Proc. Natl. Acad. Sci. U.S.A. 108 (37): 15474–9. Bibcode:2011PNAS..10815474G. doi: 10.1073/pnas.1107893108 . PMC   3174661 . PMID   21878564.
  10. 1 2 3 4 5 Vinay L, Jean-Xavier C (January 2008). "Plasticity of spinal cord locomotor networks and contribution of cation-chloride cotransporters". Brain Res Rev. 57 (1): 103–10. doi:10.1016/j.brainresrev.2007.09.003. PMID   17949820. S2CID   30698999.
  11. 1 2 3 4 5 Ginsberg MD (September 2008). "Neuroprotection for ischemic stroke: past, present and future". Neuropharmacology. 55 (3): 363–89. doi:10.1016/j.neuropharm.2007.12.007. PMC   2631228 . PMID   18308347.
  12. Báldi R, Varga C, Tamás G (October 2010). "Differential distribution of KCC2 along the axo-somato-dendritic axis of hippocampal principal cells". Eur. J. Neurosci. 32 (8): 1319–25. doi:10.1111/j.1460-9568.2010.07361.x. PMID   20880357. S2CID   11676308.
  13. Lee HH, Walker JA, Williams JR, Goodier RJ, Payne JA, Moss SJ (October 2007). "Direct protein kinase C-dependent phosphorylation regulates the cell surface stability and activity of the potassium chloride cotransporter KCC2". J. Biol. Chem. 282 (41): 29777–84. doi: 10.1074/jbc.M705053200 . PMID   17693402.
  14. 1 2 Stil A, Jean-Xavier C, Liabeuf S, Brocard C, Delpire E, Vinay L, Viemari JC (April 2011). "Contribution of the potassium-chloride co-transporter KCC2 to the modulation of lumbar spinal networks in mice". Eur. J. Neurosci. 33 (7): 1212–22. doi:10.1111/j.1460-9568.2010.07592.x. PMID   21255132. S2CID   9309418.
  15. 1 2 Uvarov P, Ludwig A, Markkanen M, Soni S, Hübner CA, Rivera C, Airaksinen MS (May 2009). "Coexpression and heteromerization of two neuronal K-Cl cotransporter isoforms in neonatal brain". J. Biol. Chem. 284 (20): 13696–704. doi: 10.1074/jbc.M807366200 . PMC   2679471 . PMID   19307176.
  16. 1 2 Blaesse P, Guillemin I, Schindler J, Schweizer M, Delpire E, Khiroug L, Friauf E, Nothwang HG (October 2006). "Oligomerization of KCC2 correlates with development of inhibitory neurotransmission". J. Neurosci. 26 (41): 10407–19. doi: 10.1523/JNEUROSCI.3257-06.2006 . PMC   6674702 . PMID   17035525.
  17. 1 2 Stil A, Liabeuf S, Jean-Xavier C, Brocard C, Viemari JC, Vinay L (December 2009). "Developmental up-regulation of the potassium-chloride cotransporter type 2 in the rat lumbar spinal cord". Neuroscience. 164 (2): 809–21. doi:10.1016/j.neuroscience.2009.08.035. PMID   19699273. S2CID   41738829.
  18. Yu, C; Yu, J; Yao, X; Wu, W. K.; Lu, Y; Tang, S; Li, X; Bao, L; Li, X; Hou, Y; Wu, R; Jian, M; Chen, R; Zhang, F; Xu, L; Fan, F; He, J; Liang, Q; Wang, H; Hu, X; He, M; Zhang, X; Zheng, H; Li, Q; Wu, H; Chen, Y; Yang, X; Zhu, S; Xu, X; et al. (2014). "Discovery of biclonal origin and a novel oncogene SLC12A5 in colon cancer by single-cell sequencing". Cell Research. 24 (6): 701–12. doi:10.1038/cr.2014.43. PMC   4042168 . PMID   24699064.
  19. 1 2 Rivera C, Li H, Thomas-Crusells J, Lahtinen H, Viitanen T, Nanobashvili A, Kokaia Z, Airaksinen MS, Voipio J, Kaila K, Saarma M (December 2002). "BDNF-induced TrkB activation down-regulates the K+-Cl cotransporter KCC2 and impairs neuronal Cl extrusion". J. Cell Biol. 159 (5): 747–52. doi:10.1083/jcb.200209011. PMC   2173387 . PMID   12473684.
  20. 1 2 Rivera C, Voipio J, Thomas-Crusells J, Li H, Emri Z, Sipilä S, Payne JA, Minichiello L, Saarma M, Kaila K (May 2004). "Mechanism of activity-dependent downregulation of the neuron-specific K-Cl cotransporter KCC2". J. Neurosci. 24 (19): 4683–91. doi: 10.1523/JNEUROSCI.5265-03.2004 . PMC   6729393 . PMID   15140939.
  21. 1 2 Kovalchuk Y, Holthoff K, Konnerth A (October 2004). "Neurotrophin action on a rapid timescale". Curr. Opin. Neurobiol. 14 (5): 558–63. doi:10.1016/j.conb.2004.08.014. PMID   15464888. S2CID   41037789.
  22. 1 2 Lee HH, Deeb TZ, Walker JA, Davies PA, Moss SJ (May 2011). "NMDA receptor activity downregulates KCC2 resulting in depolarizing GABA(A) receptor-mediated currents". Nat Neurosci. 14 (6): 736–43. doi:10.1038/nn.2806. PMC   3102766 . PMID   21532577.
  23. 1 2 Chamma I, Heubl M, Chevy Q, Renner M, Moutkine I, Eugène E, Poncer JC, Lévi S (September 2013). "Activity-dependent regulation of the K/Cl transporter KCC2 membrane diffusion, clustering, and function in hippocampal neurons". J. Neurosci. 33 (39): 15488–503. doi: 10.1523/JNEUROSCI.5889-12.2013 . PMC   6618451 . PMID   24068817.

Further reading

This article incorporates text from the United States National Library of Medicine, which is in the public domain.